Review
Open access
Sep 2026
BETA-BLOCKERS DISCONTINUATION AFTER MYOCARDIAL INFARCTION REFERRING TO EJECTION FRACTION
The clinical role of beta-blocker therapy after myocardial infarction (MI) has been debated extensively as the landscape of post-MI management has evolved. Historically, beta-blockers were established as a cornerstone of secondary prevention following landmark randomized controlled trials conducted in the 1980s (Hjalma...
Krzysztof Machnik, B. Tekieli, Wojciech Krzysztof Cyran et al.
· International Journal of Inn... · 0 citations